Back to Journals » Drug Design, Development and Therapy » Volume 13

Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura

Total article views   Abstract views HTML views PDF downloads Totals
9,078 Dovepress* 3,732 2,320+ 1,254 6,052
PubMed Central* 0 3,026 631 3,026
Totals 3,732 5,346 1,885 9,078
*Since 17 April 2019
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar